Could This Drug News Give a Lift to Eli Lilly Stock?

Could This Drug News Give a Lift to Eli Lilly Stock?

Submitted by admin on January 2, 2023 - 6:27pm
Source: 
Motley Fool
News Tags: 
Eli Lilly
Rezvoglar
diabetes
Sanofi
Lantus
biosimilars
long-acting insulin
Headline: 
Could This Drug News Give a Lift to Eli Lilly Stock?
snippet: 
  • Eli Lilly’s Rezvoglar could be a cheaper alternative to Sanofi’s Lantus.
  • The biosimilar could haul in nearly $200 million annually for the pharmaceutical giant.

Do Not Allow Advertisers to Use My Personal information